Chris Hayes is an experienced intellectual property lawyer with a background in genetics. Specializing in all aspects of IP law, Chris has held various roles in both law firms and pharmaceutical companies. With a commercial approach, Chris has worked as a barrister and partner in multiple firms before taking on positions as a Director and Member in different companies. Chris currently serves as the Chief Intellectual Property Officer at Pangea Botanica and as a Non-Executive Director at PsiClone Ltd, Neurone Ltd, and the Royal Society of Biology.
November, 2021 - present
Chief Intellectual Property Officer and VP, Legal Ops at Finjan Holdings
Chief Intellectual Property Officer at Acacia Research
Chief Intellectual Property Officer at FibroGen
Chief Intellectual Property Officer at Dominion Harbor
Chief Intellectual Property Officer at Oryzon Genomics